Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Hepatitis C transmission & prevention

HCV on the Rise in Dialysis Patients, CDC Warns

Editor's pick
MedPage Today HIV/AIDS
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Hepatitis C treatment

Kansas Legislators Walk Back On Lifetime Ban For Hepatitis C Drugs

Editor's pick
KCUR
24 January 2016
Activism & civil society

Building patient groups for viral hepatitis – a new online resource for healthcare professionals

Editor's pick
BMC Blogs Network (blog)
22 January 2016
Hepatitis C symptoms & diagnosis

Cardiovascular disease risk is higher for people with hepatitis C

News
22 January 2016
Side effects

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

News
21 January 2016
Hepatitis C symptoms & diagnosis

Hepatitis Testing Contest

Editor's pick
Social Entrepreneurship for Sexual Health
19 January 2016
New & experimental hepatitis C treatment

The 2016 Hepatitis C Drug Approval Outlook

Editor's pick
Poz
18 January 2016
Harm reduction

European Union Joint Action on HIV and Co - infection Prevention and Harm Reduction launched

Editor's pick
Manual Items
18 January 2016
Cancer

High rates of modifiable cancer risk factors present in Western HIV-positive patients

News
18 January 2016
Side effects

Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Editor's pick
Poz
14 January 2016
New & experimental hepatitis C treatment

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

Editor's pick
AbbVie press release
11 January 2016
Neurological & cognitive problems

Hepatitis C virus linked to increased risk of Parkinson's disease, studies show

News
11 January 2016
New & experimental hepatitis C treatment

Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India

Editor's pick
Mylan press release
8 January 2016
Hepatitis B

J&J signs deal with Chinese company for hepatitis B drug

Editor's pick
Reuters
8 January 2016
New & experimental hepatitis C treatment

Inside the hepatitis C virus is a promising antiviral

Editor's pick
Medical Xpress
6 January 2016
New & experimental hepatitis C treatment

Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection

Editor's pick
Gilead press release
5 January 2016
Hepatitis C treatment

The drug that costs more than $1200, and sells for $5 in India

Editor's pick
Sydney Morning Herald
3 January 2016
Hepatitis C transmission & prevention

'Half' of injecting drug users in Wales at Hepatitis C risk

Editor's pick
BBC News
3 January 2016
Hepatitis C treatment

DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates

News
30 December 2015
Hepatitis C treatment

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal

News
29 December 2015
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
Hepatitis C treatment

Australia: People Who Use Drugs Welcome Decision to ‘Seize the Day’ on New Hepatitis C Treatments

Editor's pick
Australian Injecting & Illicit Drug Users League
21 December 2015